Live Breaking News & Updates on Citius pharmaceuticals inc

Stay informed with the latest breaking news from Citius pharmaceuticals inc on our comprehensive webpage. Get up-to-the-minute updates on local events, politics, business, entertainment, and more. Our dedicated team of journalists delivers timely and reliable news, ensuring you're always in the know. Discover firsthand accounts, expert analysis, and exclusive interviews, all in one convenient destination. Don't miss a beat — visit our webpage for real-time breaking news in Citius pharmaceuticals inc and stay connected to the pulse of your community

Citius Pharmaceuticals Announces Closing of $15 Million Registered Direct Offering

Citius Pharmaceuticals Announces Closing of $15 Million Registered Direct Offering
lelezard.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from lelezard.com Daily Mail and Mail on Sunday newspapers.

New-york , United-states , Ilanit-allen , Greg-salsburg , Exchange-commission , Hc-wainwright-co , Nasdaq , Prnewswire-citius-pharmaceuticals-inc , Citius-pharmaceuticals-announces-closing , Securities-exchange , Citius-pharmaceuticals-inc , Pharmaceuticals-announces-closing

Global Induced Pluripotent Stem Cell (iPSC) Industry

Dublin, April 29, 2024 (GLOBE NEWSWIRE) -- The

Hamburg , Germany , United-states , Cambridge , Cambridgeshire , United-kingdom , Kobe , Hyogo , Japan , Taiwan , Dublin , Ireland

Citius Pharmaceuticals (CTXR) Announces $15 Million Registered Direct Offering

Citius Pharmaceuticals (CTXR) Announces $15 Million Registered Direct Offering
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

New-york , United-states , Exchange-commission , Citius-pharmaceuticals-inc , Hc-wainwright-co , Nasdaq , Citius-pharmaceuticals ,

Citius Pharmaceuticals Announces $15 Million Registered Direct Offering

/PRNewswire/ -- Citius Pharmaceuticals Inc. (Nasdaq: CTXR) ("Citius" or the "Company"), a late-stage biopharmaceutical company dedicated to the development and...

New-york , United-states , Greg-salsburg , Ilanit-allen , Citius-pharmaceuticals-inc , Exchange-commission , Hc-wainwright-co , Securities-exchange , Nasdaq , Citius-pharmaceuticals , Biologics-license-application , Citius-oncology

Comparing Citius Pharmaceuticals (NASDAQ:CTXR) and GlycoMimetics (NASDAQ:GLYC)

GlycoMimetics (NASDAQ:GLYC – Get Free Report) and Citius Pharmaceuticals (NASDAQ:CTXR – Get Free Report) are both small-cap medical companies, but which is the superior investment? We will contrast the two businesses based on the strength of their risk, profitability, institutional ownership, earnings, valuation, dividends and analyst recommendations. Analyst Recommendations This is a summary of recent […]

United-states , Rockville , Maryland , New-jersey , Citius-pharmaceuticals , National-cancer-institute , Citius-pharmaceuticals-inc , Apollomics-hong-kong , Glycomimetics-inc , Get-free-report , Given-glycomimetic

Citius Pharmaceuticals, Inc.: Citius Pharmaceuticals Announces Addition of City of Hope to UMN's Phase 1 Trial of LYMPHIR in Combination with CAR-T for the Treatment of B-Cell Lymphoma

Citius Pharmaceuticals, Inc.: Citius Pharmaceuticals Announces Addition of City of Hope to UMN's Phase 1 Trial of LYMPHIR in Combination with CAR-T for the Treatment of B-Cell Lymphoma
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

United-states , Phoenix , Arizona , California , Chicago , Illinois , University-of-minnesota , Minnesota , Orange-county , Los-angeles , Ilanit-allen , Myron-czuczman

Citius Pharmaceuticals Announces Addition of City of Hope to UMN's Phase 1 Trial of LYMPHIR in Combination with CAR-T for the Treatment of B-Cell Lymphoma

/PRNewswire/ -- Citius Pharmaceuticals, Inc. ("Citius" or the "Company") (Nasdaq: CTXR), a late-stage biopharmaceutical company developing and commercializing...

California , United-states , University-of-minnesota , Minnesota , Phoenix , Arizona , Chicago , Illinois , Orange-county , Matthew-mei , Citius-pharma , Myron-czuczman

Citius Pharmaceuticals to Present at the LD Micro Invitational XIV Investor Conference

Citius Pharmaceuticals to Present at the LD Micro Invitational XIV Investor Conference
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

New-york , United-states , Citius-pharma , Ilanit-allen , Leonard-mazur , Company-nasdaq , Sofitel , Citius-pharmaceuticals-inc , Prnewswire-citius-pharmaceuticals-inc , Citius-pharmaceuticals , Biologics-license-application , Citius-oncology

Mesenchymal Stem Cells / Medicinal Signaling Cells (MSCs) Advancements & Future Forecasts through 2030

/PRNewswire/ -- The "Mesenchymal Stem Cells / Medicinal Signaling Cells (MSCs) - Advances & Applications, 2023" report has been added to...

China , South-korea , Maryland , United-states , Dublin , Ireland , Japan , American , Evotec-biologics , Waisman-biomanufacturing , Yapan-bio , Arranta-bio

Citius Pharmaceuticals Announces Filing of Form S-3 Shelf Registration Statement to Replace Expiring Prior Shelf Registration

CRANFORD, N.J., Feb. 26, 2024 /PRNewswire/ -- Citius Pharmaceuticals, Inc. , a late-stage biopharmaceutical company dedicated to the development and commercialization of first-in-class critical...

Ilanit-allen , Citius-pharma , Citius-pharmaceuticals-inc , Company-nasdaq , Prnewswire-citius-pharmaceuticals-inc , Exchange-commission , Citius-pharmaceuticals , Biologics-license-application , Citius-oncology , Markets ,